A Review on Vadadustat: Hope in Treatment of Anemia Patients Having Chronic Kidney Disease
Nikita Gupta, Mohd Naveed Khan, Varda Farooqui, Guntoju Poojitha & Thipparam Kavya · Asian Journal of Immunology · 2024
Vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, may offer an oral alternative to injectable erythropoiesis-stimulating agents (ESAs) to treat anemia in patients undergoing peritoneal dialysis. Current standard of care for anemia linked to chronic kidney disea...
Open access
Research Article
10.9734/aji/2024/v7i1153